Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
3mS0cdwbfWftmqqW
Listen
